These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25753991)

  • 1. pH-responsive artemisinin dimer in lipid nanoparticles are effective against human breast cancer in a xenograft model.
    Zhang YJ; Zhan X; Wang L; Ho RJ; Sasaki T
    J Pharm Sci; 2015 May; 104(5):1815-24. PubMed ID: 25753991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of paclitaxel-loaded poly (2-hydroxyethyl methacrylate)-g-poly (lactide)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine copolymer nanoparticle delivery system and evaluation of its anticancer activity.
    Ma X; Wang H; Jin S; Wu Y; Liang XJ
    Int J Nanomedicine; 2012; 7():1313-28. PubMed ID: 22419875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment.
    Yu D; Li W; Zhang Y; Zhang B
    Biomed Pharmacother; 2016 Oct; 83():1428-1435. PubMed ID: 27592131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-responsive artemisinin derivatives and lipid nanoparticle formulations inhibit growth of breast cancer cells in vitro and induce down-regulation of HER family members.
    Zhang YJ; Gallis B; Taya M; Wang S; Ho RJ; Sasaki T
    PLoS One; 2013; 8(3):e59086. PubMed ID: 23516601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LyP-1 modification to enhance delivery of artemisinin or fluorescent probe loaded polymeric micelles to highly metastatic tumor and its lymphatics.
    Wang Z; Yu Y; Ma J; Zhang H; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
    Mol Pharm; 2012 Sep; 9(9):2646-57. PubMed ID: 22853186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotin-functionalized copolymeric PEG-PCL micelles for in vivo tumour-targeted delivery of artemisinin.
    Nosrati H; Barzegari P; Danafar H; Kheiri Manjili H
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):104-114. PubMed ID: 30663422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanovector Assembled from Natural Egg Yolk Lipids for Tumor-Targeted Delivery of Therapeutics.
    Tang Z; Luo C; Jun Y; Yao M; Zhang M; He K; Jin L; Ma J; Chen S; Sun S; Tao M; Ding L; Sun X; Chen X; Zhang L; Gao Y; Wang QL
    ACS Appl Mater Interfaces; 2020 Feb; 12(7):7984-7994. PubMed ID: 31971362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells.
    Abumanhal-Masarweh H; da Silva D; Poley M; Zinger A; Goldman E; Krinsky N; Kleiner R; Shenbach G; Schroeder JE; Shklover J; Shainsky-Roitman J; Schroeder A
    J Control Release; 2019 Aug; 307():331-341. PubMed ID: 31238049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel.
    Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Guo X; Chen D
    Int J Pharm; 2015 Mar; 480(1-2):116-27. PubMed ID: 25615984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
    Chen HH; Huang WC; Chiang WH; Liu TI; Shen MY; Hsu YH; Lin SC; Chiu HC
    Int J Nanomedicine; 2015; 10():5035-48. PubMed ID: 26346762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of cytotoxicity of artemisinin toward cancer cells by transferrin-mediated carbon nanotubes nanoparticles.
    Zhang H; Ji Y; Chen Q; Jiao X; Hou L; Zhu X; Zhang Z
    J Drug Target; 2015; 23(6):552-67. PubMed ID: 25754587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles.
    Zhigaltsev IV; Winters G; Srinivasulu M; Crawford J; Wong M; Amankwa L; Waterhouse D; Masin D; Webb M; Harasym N; Heller L; Bally MB; Ciufolini MA; Cullis PR; Maurer N
    J Control Release; 2010 Jun; 144(3):332-40. PubMed ID: 20202473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs.
    Huang ZR; Tipparaju SK; Kirpotin DB; Pien C; Kornaga T; Noble CO; Koshkaryev A; Tran J; Kamoun WS; Drummond DC
    J Control Release; 2019 Sep; 310():47-57. PubMed ID: 31400383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-targeted delivery of paclitaxel using low density lipoprotein-mimetic solid lipid nanoparticles.
    Kim JH; Kim Y; Bae KH; Park TG; Lee JH; Park K
    Mol Pharm; 2015 Apr; 12(4):1230-41. PubMed ID: 25686010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin loaded chitosan magnetic nanoparticles for the efficient targeting to the breast cancer.
    Natesan S; Ponnusamy C; Sugumaran A; Chelladurai S; Shanmugam Palaniappan S; Palanichamy R
    Int J Biol Macromol; 2017 Nov; 104(Pt B):1853-1859. PubMed ID: 28359890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy.
    Zhang C; Zhao Y; Zhang E; Jiang M; Zhi D; Chen H; Cui S; Zhen Y; Cui J; Zhang S
    Drug Deliv; 2020 Dec; 27(1):1397-1411. PubMed ID: 33096948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-dendrimer hybrid nanosystem as a novel delivery system for paclitaxel to treat ovarian cancer.
    Liu Y; Ng Y; Toh MR; Chiu GNC
    J Control Release; 2015 Dec; 220(Pt A):438-446. PubMed ID: 26551345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
    Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designed Synthesis of Lipid-Coated Polyacrylic Acid/Calcium Phosphate Nanoparticles as Dual pH-Responsive Drug-Delivery Vehicles for Cancer Chemotherapy.
    Wang X; Zhang M; Zhang L; Li L; Li S; Wang C; Su Z; Yuan Y; Pan W
    Chemistry; 2017 May; 23(27):6586-6595. PubMed ID: 28218434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.